Product
Tafenoquine
Aliases
KODATEF™, Kozenis, Tafenoquine Oral Tablet
Name
Arakoda
INN Name
Tafenoquine
FDA Approved
Yes
10 clinical trials
1 organization
11 indications
1 document
Indication
BabesiosisIndication
COVID-19Indication
Infectious DiseaseIndication
SARS-CoV-2Indication
MalariaIndication
VivaxIndication
Malaria caused by Plasmodium vivaxIndication
Plasmodium Vivax MalariaIndication
Plasmodium VivaxIndication
Lactating WomenClinical trial
A Double-blind Placebo-controlled Study to Assess the Safety and Efficacy of Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care in Patients Hospitalized for BabesiosisStatus: Not yet recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression (the "ACLR8-LR" Study)Status: Not yet recruiting, Estimated PCD: 2024-04-27
Clinical trial
A Double-blind Placebo-controlled Study to Assess the Efficacy and Safety of Oral Tafenoquine Versus Placebo in Patients With Mild to Moderate COVID-19 DiseaseStatus: Completed, Estimated PCD: 2022-06-30
Clinical trial
Operational Feasibility of Appropriate Plasmodium Vivax Radical Cure With Tafenoquine or Primaquine After Quantitative G6PD Testing in ThailandStatus: Completed, Estimated PCD: 2023-08-31
Clinical trial
A Revised Tafenoquine Dose to Improve Radical Cure for Vivax Malaria - TAfenoquine DOsing REvisedStatus: Not yet recruiting, Estimated PCD: 2027-03-01
Clinical trial
Optimizing the Dose of Tafenoquine for the Radical Cure of Plasmodium Vivax Malaria in Southeast AsiaStatus: Not yet recruiting, Estimated PCD: 2027-12-31
Clinical trial
Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine - a Randomized Controlled Trial in P. Vivax PatientsStatus: Recruiting, Estimated PCD: 2024-09-30
Clinical trial
Breastfed Child Exposure to Tafenoquine and Primaquine During Treatment in Lactating Women: a Pharmacokinetic Study in Healthy VolunteersStatus: Withdrawn, Estimated PCD: 2025-06-30
Clinical trial
Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in BrazilStatus: Active (not recruiting), Estimated PCD: 2022-08-30
Clinical trial
Expanded Access Protocol: Use of Tafenoquine for Treatment of Babesiosis in Immunocompromised Patients With Persistent Babesia Microti Despite Prior TreatmentStatus:
Document
DailyMed Label: ArakodaOrganization
60 Degrees Pharmaceuticals, LLC